Leucomethylene blue mesylate

SKU: orb1300151

Description

TRx0237 mesylate, also known as Leucomethylene blue mesylate, is a second-generation inhibitor targeting tau protein aggregation. It is utilized in research for Alzheimer's and frontotemporal dementia, with studies demonstrating its effects in both cellular and animal models of tauopathy.

Research Area

Neuroscience, Signal Transduction

Key Properties

• Target: Microtubule Associated,Beta Amyloid
• Molecular Weight: 477.62
• Purity: 97.06% (May vary between batches)
• CAS Number: 1236208-20-0
• Formula: C₁₆H₁₉N₃S·2CH₄O₃S
• SMILES: CS(O)(=O)=O.CS(O)(=O)=O.CN(C)c1ccc2Nc3ccc(cc3Sc2c1)N(C)C

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Disease, Beta Amyloid, BetaAmyloid, Amyloid-β, bAmyloid, Aβ25-35, b Amyloid, Alzheimer's, aggregation, Abeta, inhibit, Methylene blue leuco base, Methylene blue leuco base Mesylate, Methylene blue leuco base mesylate salt, Microtubule Associated, MicrotubuleAssociated, Inhibitor, Leucomethylene Blue, Leucomethylene blue, Leucomethylene Blue Dimesylate, Leucomethylene blue Mesylate, Leucomethylene blue mesylate, Tau aggregation, Tau, βAmyloid, β Amyloid, β-amyloid peptide, TRx 0237, TRx0237, TRx-0237, TRx0237 (LMTX) Mesylate, TRx0237 (LMTX) mesylate, TRx0237 mesylate, TRx0237 Mesylate

Compound Identifiers

PubChem CID

60150609